To confirm that the reduced tumor sizes are caused by TRK inhibition, we performed immunohistochemical staining of tissues of tumors from the vehicle and 40 mpk AZD4547 treated group (Figure 5D). The gene discussed is TPM3; the disease is neoplasm.